Amyloid formation of bovine insulin is retarded in moderately acidic pH and by addition of short-chain alcohols.
2-Propanol
/ chemistry
Alcohols
/ chemistry
Amyloid
/ chemistry
Animals
Benzothiazoles
/ chemistry
Buffers
Cattle
Circular Dichroism
Ethanol
/ chemistry
Hydrogen-Ion Concentration
Insulin
/ chemistry
Isoelectric Point
Kinetics
Microscopy, Atomic Force
Microscopy, Fluorescence
Protein Binding
Solubility
Solvents
Aggregation
Amyloid
Circular dichroism
Insulin
Kinetics
Thioflavin-T
Journal
European biophysics journal : EBJ
ISSN: 1432-1017
Titre abrégé: Eur Biophys J
Pays: Germany
ID NLM: 8409413
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
14
06
2019
accepted:
22
12
2019
revised:
20
12
2019
pubmed:
7
1
2020
medline:
15
12
2020
entrez:
6
1
2020
Statut:
ppublish
Résumé
Protein aggregation and amyloid formation are associated with multiple human diseases, but are also a problem in protein production. Understanding how aggregation can be modulated is therefore of importance in both medical and industrial contexts. We have used bovine insulin as a model protein to explore how amyloid formation is affected by buffer pH and by the addition of short-chain alcohols. We find that bovine insulin forms amyloid fibrils, albeit with different rates and resulting fibril morphologies, across a wide pH range (2-7). At pH 4.0, bovine insulin displayed relatively low aggregation propensity in combination with high solubility; this condition was therefore chosen as basis for further exploration of how bovine insulin's native state can be stabilized in the presence of short-chain alcohols that are relevant because of their common use as eluents in industrial-scale chromatography purification. We found that ethanol and isopropanol are efficient modulators of bovine insulin aggregation, providing a three to four times retardation of the aggregation kinetics at 30-35% (vol/vol) concentration; we attribute this to the formation of oligomers, which we detected by AFM. We discuss this effect in terms of reduced solvent polarity and show, by circular dichroism recordings, that a concomitant change in α-helical packing of the insulin monomer occurs in ethanol. Our results extend current knowledge of how insulin aggregates, and may, although bovine insulin serves as a simplistic model, provide insights into how buffers and additives can be fine-tuned in industrial production of proteins in general and pharmaceutical insulin in particular.
Identifiants
pubmed: 31901953
doi: 10.1007/s00249-019-01420-0
pii: 10.1007/s00249-019-01420-0
pmc: PMC7069927
doi:
Substances chimiques
Alcohols
0
Amyloid
0
Benzothiazoles
0
Buffers
0
Insulin
0
Solvents
0
thioflavin T
2390-54-7
Ethanol
3K9958V90M
2-Propanol
ND2M416302
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
145-153Subventions
Organisme : Vetenskapsrådet
ID : 2016-03902
Références
Biochem J. 1986 Aug 1;237(3):663-8
pubmed: 3099757
Int J Pharm. 2005 Jan 31;289(1-2):1-30
pubmed: 15652195
Biochem Biophys Res Commun. 2015 Mar 6;458(2):418-23
pubmed: 25660454
Biophys Chem. 2010 May;148(1-3):28-33
pubmed: 20202737
Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003816
pubmed: 15674916
Biochemistry. 1990 Oct 2;29(39):9289-93
pubmed: 2271596
Biochemistry. 2001 May 22;40(20):6036-46
pubmed: 11352739
J Mol Biol. 1997 Oct 31;273(3):729-39
pubmed: 9356260
Biophys J. 2000 Aug;79(2):1053-65
pubmed: 10920035
Diabetes Res Clin Pract. 2007 Mar;75(3):374-6
pubmed: 16930758
Biochemistry. 2002 Dec 17;41(50):14700-15
pubmed: 12475219
Science. 2008 Mar 7;319(5868):1405-8
pubmed: 18323455
Hum Pathol. 2009 Nov;40(11):1655-60
pubmed: 19683329
Fed Proc. 1946;5(1 Pt 2):111
pubmed: 21023566
Biochemistry. 1974 Oct 22;13(22):4566-74
pubmed: 4473202
FEBS Lett. 2005 Jul 4;579(17):3574-8
pubmed: 15964569
J Pharm Sci. 1997 May;86(5):517-25
pubmed: 9145374
Nat Protoc. 2016 Feb;11(2):252-72
pubmed: 26741409
Appl Microbiol Biotechnol. 2005 Apr;67(2):151-9
pubmed: 15580495
EMBO J. 2002 Nov 1;21(21):5682-90
pubmed: 12411486
Phys Chem Chem Phys. 2018 Nov 7;20(43):27638-27645
pubmed: 30374505
Pharm Biotechnol. 1993;5:315-50
pubmed: 8019699
Biochemistry. 2017 Apr 25;56(16):2170-2174
pubmed: 28402629
Biochemistry. 1972 Jun 20;11(13):2435-9
pubmed: 5040649
Biochemistry. 1972 Oct 24;11(22):4013-6
pubmed: 4673642
Nat Rev Drug Discov. 2005 Apr;4(4):298-306
pubmed: 15803194
Amyloid. 2016 Sep;23(3):139-147
pubmed: 27159045
J Biol Chem. 1984 Nov 10;259(21):13253-61
pubmed: 6490655
Biochemistry. 2005 Jun 28;44(25):8948-58
pubmed: 15966720
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 15;853(1-2):354-9
pubmed: 17349827
Diabetologia. 1988 Mar;31(3):158-61
pubmed: 3286343
Philos Trans R Soc Lond B Biol Sci. 2001 Feb 28;356(1406):133-45
pubmed: 11260793
Annu Rev Biochem. 2006;75:333-66
pubmed: 16756495